Skip to content
Review

The Microbiome-Gut-Brain Axis: Decoding the Molecular Dialogue for Next-Generation Neurotherapeutics.

Sep 2026 · Current Neuropharmacology · 0 citations
Medicine

TL;DR

A forward-looking roadmap is concluded that emphasizes multi-omics integration, standardization, human-relevant disease models, and personalized therapeutic strategies to decode the MGBA and exploit its full potential, which could revolutionize the treatment of brain disorders.

Abstract

The human brain has traditionally been considered an isolated organ until the establishment of the microbiome-gut-brain axis (MGBA) overturned that concept. Based on recent reports, the present review provides confirmatory evidence that there is a complex communication in the MGBA that links the central nervous system with the resident microbial community of the gastrointestinal tract. A complex, highly sophisticated molecular dialogue involving immune and neuroinflammatory molecules, signaling via the vagus nerve and neural pathways, and key metabolic and endocrine routes facilitates cross-talk between the brain and the gut microbiome. Crucial microbial metabolites, such as bile acids and short-chain fatty acids (SCFAs), neurotransmitter release, and modulation of systemic inflammation are highlighted as primary mediators of gut-brain interactions. In recent times, research has shifted from establishing associations to elucidating precise mechanisms between brain physiology and the composition of the gut microbial community. Recent studies have emphasized linking specific bacterial taxa to neurological outcomes in Alzheimer's disease (AD), Parkinson's disease (PD), and autism spectrum disorder (ASD). Emerging therapeutic modalities such as engineered live biotherapeutics, next-generation psychobiotics, precision nutrition, and fecal microbiota transplantation are promising avenues for next-generation neurotherapeutics. However, the path to clinical translation is fraught with challenges, including methodological heterogeneity and reproducibility, establishing causality, and confounding host factors. This review concludes with a forward-looking roadmap that emphasizes multi-omics integration, standardization, human-relevant disease models, and personalized therapeutic strategies to decode the MGBA and exploit its full potential, which could revolutionize the treatment of brain disorders.

View source

Similar papers

Review Open access Sep 2026

THE GUT–BRAIN AXIS IN NEUROLOGICAL DISORDERS: FROM MICROBIAL DYSBIOSIS TO THERAPEUTIC INTERVENTION

The link between gut dysbiosis and clinically significant neurological disorders including multiple sclerosis, Alzheimer's disease, Parkinson's disease, epilepsy, stroke, and neuropsychiatric disorders is extensively analyzed, and the research considers novel microbiome-based approaches, probiotics, prebiotics, synbiot...

Bhoomi Aggarwal, Nyasa Pandey, S. Anand et al. · 0 citations
Review Open access Aug 2026

THE GUT–BRAIN AXIS: THE INFLUENCE OF THE INTESTINAL MICROBIOME ON NEUROINFLAMMATION AND MENTAL HEALTH

The gut-brain axis is a complex bidirectional communication system between the gastrointestinal tract and the central nervous system, in which the intestinal microbiota may contribute to the modulation of immune, metabolic, neuroendocrine, and neural processes. This study aimed to analyze evidence on the relationship b...

Anderson Leandro Kovalski, Naiara Cristina de Souza Garajau, A. Coelho et al. · 0 citations
Review Sep 2026

Psychobiotics and the microbiota-gut-brain axis: a comprehensive review of mechanisms, efficacy, and translational challenges.

Current clinical and preclinical literature demonstrates that specific taxa, particularly within the Lactobacilli and Bifidobacterium genera, can attenuate stress reactivity, reduce systemic inflammation, and regulate hypothalamic-pituitary-adrenal axis hyperactivity.

Abdul Mannan Faruk Ahmed, Akhiljith, Sandhya Balasubramanian et al. · 0 citations
Review Open access Aug 2026

Gut-to-brain signaling: New frontiers in treating brain disorders.

ABSTRACT The microbiota.gut.brain axis is essential for maintaining body balance. This review evaluates how altering this connection can treat various central nervous system disorders. First, we examine how the gut and brain communicate through neural pathways, immune responses, and chemical signals. We focus particula...

Hong-yan Pei, Ying-Hua Yao, Li Xu et al. · 0 citations
Review Open access Oct 2026

Targeting the gut–brain axis: novel strategies for disease intervention from mechanisms to clinical practice

The gut–brain axis is a bidirectional communication network linking the gastrointestinal tract and the central nervous system (CNS), in which the gut microbiota and its metabolites have emerged as important modulators. Alterations in the gut microbiota have been reported in a range of neurological, psychiatric, and met...

Le-Le Fan, Yu Guo, Jin Liu et al. · 0 citations
Review Open access Aug 2026

Glycosylation in gut-brain communication: from the intestinal barrier and microbiota to immune and neural signaling

Abstract The gut-brain axis is a complex bidirectional communication network linking the gastrointestinal tract and the central nervous system. Its dysregulation is closely associated with a wide range of gastrointestinal, metabolic, and neuropsychiatric disorders. Glycosylation, one of the most prevalent and structura...

Dan Wang, Dong Zhou, Jian-Guo Gu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.